Cantor Fitzgerald Reiterates Overweight on Eli Lilly (LLY) Despite Medicare Coverage Risks, Still Sees Clear Path for Coverage Contingent on Successful Phase 3

Go back to Cantor Fitzgerald Reiterates Overweight on Eli Lilly (LLY) Despite Medicare Coverage Risks, Still Sees Clear Path for Coverage Contingent on Successful Phase 3
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 209.75 -0.08 (0.04%)
Previous Close $209.83    52 Week High $333.65 
Open $208.36    52 Week Low $223.02 
Day High $209.84    P/E 26.86 
Day Low $207.62    EPS $7.81 
Volume 63,704       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1190.00 +9.84 (0.83%)
Previous Close $1180.16    52 Week High $88.16 
Open $1175.20    52 Week Low $67.88 
Day High $1190.65    P/E 275.46 
Day Low $1163.50    EPS $4.32 
Volume 310,951